Skip to main content
. Author manuscript; available in PMC: 2012 Mar 20.
Published in final edited form as: Cell Tissue Res. 2011 Jun 22;347(3):575–588. doi: 10.1007/s00441-011-1197-3

Fig. 7.

Fig. 7

Qualitative mineral formation at the defect site after in vivo delivery of AAV-coated PCL scaffolds with or without pre-seeding of hMSCs. Radiographic (a–h) and in vivo micro-CT (i–l) images from defects that had the representative mineral formation per group, together with the bony bridging rate for each treatment group